Hypomethylation of CYP2E1 and DUSP22 promoters associated with disease activity and erosive disease among rheumatoid arthritis patients

ConclusionMethylation signatures specific to RA clinical outcomes may have utility as biomarkers or predictors of exposure, disease progression and severity.This article is protected by copyright. All rights reserved.

Source: Arthritis and Rheumatism - December 29, 2017 Category: Rheumatology Authors: Amanda Mok, Brooke Rhead, Calliope Holingue, Xiaorong Shao, Hong L. Quach, Diana Quach, Elizabeth Sinclair, Jonathan Graf, John Imboden, Thomas Link, Ruby Harrison, Vladimir Chernitskiy, Lisa F. Barcellos, Lindsey A. Criswell Tags: Full Length Source Type: research